Novel Immuno-Oncology therapy: Current status of clinical research and prospect of application

Shi Jia Zhang, Sheng Xiang Ren

Research output: Contribution to journalArticlepeer-review

Abstract

Recently, immune-oncologic therapy advanced rapidly and has been defined as another option, following surgery, radiotherapy, chemotherapy and molecular targeted therapy, for treatment of malignant diseases. To date, several immune checkpoint inhibitors and compounds have been approved to treat various of malignant diseases with efficiency. Meanwhile, more and more potential therapeutic targets in processes of the cancer immunity have been noticed. We aimed to summarize the research status and clinical prospects of novel immune-oncologic treatment agencies targeted to different steps of the cancer-immunity cycle.

Original languageEnglish (US)
Pages (from-to)645-651
Number of pages7
JournalChinese Journal of Lung Cancer
Volume20
Issue number9
DOIs
StatePublished - Jan 1 2017

Keywords

  • Immune checkpoint inhibitor
  • Immuno-oncology therapy
  • Neoplasms

Fingerprint Dive into the research topics of 'Novel Immuno-Oncology therapy: Current status of clinical research and prospect of application'. Together they form a unique fingerprint.

Cite this